External broker reports(aggregated public sources), Prabhudas Lilladhar

Prabhudas Lilladhar

External broker reports(aggregated public sources)

Prabhudas Lilladher is one of India's leading research based financial services organisation.

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Prabhudas Lilladher's research report onAxis Bank AXSB delivered a good quarter as core PPoP beat PLe by 3.6% driven by better fees and NII.</li><li>While loan growth at 14.2% YoY was a slight miss (86bps), reported NIM increased by 5bps QoQ to 4.06%, which was a positive given NIM environment is tough.</li><li>Balance sheet profile has been improving since (1) share of higher yielding retail (incl.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Prabhudas Lilladher's research report onAxis Bank AXSB delivered a good quarter as core PPoP beat PLe by 3.6% driven by better fees and NII.While loan growth at 14.2% YoY was a slight miss (86bps), reported NIM increased by 5bps QoQ to 4.06%, which was a positive given NIM environment is tough.Balance sheet profile has been improving since (1) share of higher yielding retail (incl.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Axis Bank - Balance Sheet Profile to Cushion NIM

External broker reports(aggregated public sources), Emkay Global Financial Services Limited

Emkay

Emkay Global Financial Services Limited

Emkay Global Financial Services Ltd. is a leader in the financial services sector, actively creating wealth for our clients for over two decades. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>Emkay Global Financial's research report onAxis Bank Despite slower credit growth at 14% YoY/3.5% QoQ, Axis Bank reported 5bps QoQ margin expansion, mainly on a contained rise in CoF and steady increase in share of retail portfolio.</li><li>This, along with higher trading gains, partly offset by elevated opex &amp; provision, led to a 5% beat on PAT at Rs71.3bn.</li><li>Mgmt guides systemic credit growth slowing down in FY25, but expects Axis Bank to outgrow the system mainly led by continued traction in retail which, in turn, should support its margins.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Emkay Global Financial's research report onAxis Bank Despite slower credit growth at 14% YoY/3.5% QoQ, Axis Bank reported 5bps QoQ margin expansion, mainly on a contained rise in CoF and steady increase in share of retail portfolio.This, along with higher trading gains, partly offset by elevated opex &amp; provision, led to a 5% beat on PAT at Rs71.3bn.Mgmt guides systemic credit growth slowing down in FY25, but expects Axis Bank to outgrow the system mainly led by continued traction in retail which, in turn, should support its margins.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Axis Bank - Steady Retail Build-Up Aids Margin Expansion

External broker reports(aggregated public sources), ICICI Securities Ltd

ICICI Securities Limited

ICICI Securities Ltd

ICICI Securities Limited provides investment services. The Company provides corporate and investment banking, securities, wealth management, retail brokerage, initial public offerings, and advisory services. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>ICICI Securities research report onAxis Bank Driven by NIM uptick (vs. our estimate of decline), bulky treasury gains and contained opex, Axis Bank (Axis) reported a strong Q4FY24 PAT of INR 71.3bn.</li><li>Reported RoA came in at a historical high of 2.0%, while asset quality remained comfortable.</li><li>Other positives in the results were improvement in LDR (down to 90% vs. 93%), uptick in LCR (120% vs. 118% QoQ) and PSL compliance on overall as well as sub-segment basis.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

ICICI Securities research report onAxis Bank Driven by NIM uptick (vs. our estimate of decline), bulky treasury gains and contained opex, Axis Bank (Axis) reported a strong Q4FY24 PAT of INR 71.3bn.Reported RoA came in at a historical high of 2.0%, while asset quality remained comfortable.Other positives in the results were improvement in LDR (down to 90% vs. 93%), uptick in LCR (120% vs. 118% QoQ) and PSL compliance on overall as well as sub-segment basis.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Axis Bank - Strong Quarter with Historical High RoA of 2.0%

Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

SAI Life Sciences / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sai-life-sciences" target="_blank" data-smartkarma-citation="entities:43724:1" rel="noopener">SAI Life Sciences</a>(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.</li>
<li>SLS is a CRDMO. It provides end-to-end services across the drug discovery, development and manufacturing value chain, for small molecule NCE to global pharmaceutical innovators and biotechnology firms</li>
<li>As per Frost &amp; Sullivan, SLS was the fastest-growing Indian CRDMOs among listed Indian peers in terms of revenue CAGR as well as EBITDA CAGR from FY22 to FY24.</li>
</ul>



SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.
SLS is a CRDMO. It provides end-to-end services across the drug discovery, development and manufacturing value chain, for small molecule NCE to global pharmaceutical innovators and biotechnology firms
As per Frost &amp; Sullivan, SLS was the fastest-growing Indian CRDMOs among listed Indian peers in terms of revenue CAGR as well as EBITDA CAGR from FY22 to FY24.


Specialist in Indian Banking and Economic Research

Hemindra Hazari

<ul>
<li>Sudden resignation of Ravi Narayanan Group-Head in charge of retail branches, retail liabilities and third party products as he wishes to pursue entrepreneurship.</li>
<li>Possible explanation is that the bank like other banks is finding it difficult to raise retail deposits and pressure is building up on senior management</li>
<li>Bank has a high LDR and reportedly the banking regulator is demanding the bank to lower its LDR. This will have consequences on future loan growth or on NIM</li>
</ul>


Sudden resignation of Ravi Narayanan Group-Head in charge of retail branches, retail liabilities and third party products as he wishes to pursue entrepreneurship.
Possible explanation is that the bank like other banks is finding it difficult to raise retail deposits and pressure is building up on senior management
Bank has a high LDR and reportedly the banking regulator is demanding the bank to lower its LDR. This will have consequences on future loan growth or on NIM


Axis Bank Incubates a New Entrepreneur -- Its Head of Retail Branches

India

Axis Bank Limited provides a full range of banking services throughout India. The Group's activities include retail banking, investment management, merchant banking, treasury and NRI services, cash and credit management services, and ATM facilities.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Axis Bank Ltd (AXSB IN)

Axis Bank - Balance Sheet Profile to Cushion NIM

Prabhudas Lilladher's research report onAxis Bank AXSB delivered a good quarter as core PPoP beat PLe by 3.6% driven by better fees and NII.

Prabhudas Lilladhar

Axis Bank - Steady Retail Build-Up Aids Margin Expansion

Emkay Global Financial's research report onAxis Bank Despite slower credit growth at 14% YoY/3.5% QoQ, Axis Bank reported 5bps QoQ margin expansion

Emkay

Axis Bank - Strong Quarter with Historical High RoA of 2.0%

Other positives in the results were improvement in LDR (down to 90% vs. 93%), uptick in LCR (120% vs. 118% QoQ) and PSL compliance on overall as...

ICICI Securities Limited

Sai Life Sciences Pre-IPO Tearsheet

SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.

Sumeet Singh

Axis Bank Incubates a New Entrepreneur -- Its Head of Retail Branches

Ravi Narayanan resigns from bank to pursue entrepreneurship amid pressure to raise retail deposits and lower LDR, impacting loan growth and NIM.

Hemindra Hazari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Axis Bank - Balance Sheet Profile to Cushion NIM

Prabhudas Lilladher's research report onAxis Bank AXSB delivered a good quarter as core PPoP beat PLe by 3.6% driven by better fees and NII.

Prabhudas Lilladhar

Axis Bank - Steady Retail Build-Up Aids Margin Expansion

Emkay Global Financial's research report onAxis Bank Despite slower credit growth at 14% YoY/3.5% QoQ, Axis Bank reported 5bps QoQ margin expansion

Emkay

Axis Bank - Strong Quarter with Historical High RoA of 2.0%

Other positives in the results were improvement in LDR (down to 90% vs. 93%), uptick in LCR (120% vs. 118% QoQ) and PSL compliance on overall as...

ICICI Securities Limited

Sai Life Sciences Pre-IPO Tearsheet

SAI Life Sciences(SLS) is looking to raise up to US$500m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and MS.

Sumeet Singh

Axis Bank Incubates a New Entrepreneur -- Its Head of Retail Branches

​Ravi Narayanan resigns from bank to pursue entrepreneurship amid pressure to raise retail deposits and lower LDR, impacting loan growth and NIM.

Hemindra Hazari

Ravi Narayanan resigns from bank to pursue entrepreneurship amid pressure to raise retail deposits and lower LDR, impacting loan growth and NIM.